VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISA 2022 | Strategies to manage renal AA amyloidosis and advances in this space

In this video, Peter Kvacskay, MD, Heidelberg University Hospital, Heidelberg, Germany, shares some insights into strategies used to manage patients with renal AA amyloidosis, including interleukin-1 blocking agents such as anakinra and canakinumab, and renal transplantation. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter